NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108, NDC 72426-818-03
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot #, 1990305, Exp 08-31-2025
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Esperion
- Reason for Recall:
- Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- completed
Product Information
Full Description:
NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108, NDC 72426-818-03
Product Codes/Lot Numbers:
Lot #, 1990305, Exp 08-31-2025
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-0441-2024
Related Recalls
Class I - Dangerous
Failed dissolution specifications: below specification results at stability 12-month